IP Group plc

Board changes

IP Group plc

Portfolio company Oxford Nanopore priced at £3.4billion, IP Group generates £84m of proceeds*; retains holding valued at £348.8m

IP Group plc

Portfolio company Oxford Nanopore confirms Intention to Float on the London Stock Exchange; cornerstone investment agreement with Oracle

IP Group plc

New charitable initiatives - new long-term charity partner, IntoUniversity, volunteering days policy and additional one-off donation to 20 charities

IP Group plc

Half-yearly Results

IP Group plc

Portfolio company Artios Pharma raises $153m (£110m*)

IP Group plc

Portfolio company Apollo Therapeutics raises $145m

IP Group plc

AGM statement

IP Group plc

Portfolio company Iksuda Therapeutics completes $42m (£29.6m*) Series A financing round

IP Group plc

Forms joint venture with China Everbright Ltd to launch a £167m* (RMB1.5bn) fund in China